NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘biopharma’

24 March 2015

New VCs help anti-cancer treatment pioneer Rigontec push Series A to €14.25m

Dutch early stage investor Forbion Capital Partners and Danish peer Sunstone Capital have brought biopharma business Rigontec's Series A round to €14.25m through a second close.

3 March 2015

Rock Springs, Sofinnova in cool $70m Series E for biopharma company Chiasma

syringe-m Venture capital investors Rock Springs Capital and Sofinnova Ventures have taken part in a sizable $70m funding round for US biopharmaceutical Chiasma.

23 February 2015

VC-backed Heptares Therapeutics sold to Japanese trade partner for $400m

sold-sale-exit-deal UK biopharmaceutical Heptares Therapeutics, whose backers have included MVM Life Science Partners, Novartis Venture Fund and Takeda Ventures, has been sold to Tokyo-listed pharma company Sosei Group Corporation.

16 February 2015

LSP-backed biophama company ActoGeniX picked up by trade partner

chemicals-995871-m Biopharma company ActoGenix, which ranks among Life Sciences Partners (LSP) portfolio investments, has been bought by strategic investor Intrexon Corporation.

12 November 2014

Skin disease treatment business gets $33.1m in NEA, Lundbeckfond-led Series B round

skin5_lrg New Enterprise Associates and Lundbeckfond Ventures have led a $33.1m Series B financing round for inflammatory skin disease-treating biopharma business Ziarco.

19 June 2014

Polaris backs biopharmaceutical startup Navitor’s $23.5m Series A

navitor Biopharmaceutical company Navitor Pharmaceuticals has raised a $23.5m Series A round from venture capital backer.

8 April 2014

Lightstone Ventures secures more than $150m for debut fund $

life science test tube_sq Life sciences-focused venture capital firm Lightstone Ventures has passed the halfway mark for its debut fund, AltAssets has learned.

11 March 2014

Lumena Pharmaceuticals raises $45m in NEA-led Series B

biotech_lrg New Enterprise Associates led a $45m Series B round for biopharmaceutical company Lumena Pharmaceuticals, which is focused on developing products for rare cholestatic liver diseases and serious metabolic disorders.

7 February 2014

Eleven Biotherapeutics raises $50m via IPO

dollar envelope money Venture capital-backed biopharmaceutical company Eleven Biotherapeutics has raised $50m via an IPO on the Nasdaq exchange.

19 September 2013

Valuations in life sciences sector climb 15% in second quarter $

biotech_lrg Company valuations in the US life sciences sector increased at a slower pace in the second quarter compared to the first three months of the year, according to a recent report.

Page 1 of 3123

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015